These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16294902)

  • 1. Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.
    Grégoire V
    Rays; 2005; 30(2):105-8. PubMed ID: 16294902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCP and NTCP: a basic introduction.
    Baumann M; Petersen C
    Rays; 2005; 30(2):99-104. PubMed ID: 16294901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in radiotherapy for carcinoma of the head and neck.
    Morris MM; Schmidt-Ullrich R; Johnson CR
    Surg Oncol Clin N Am; 2000 Jul; 9(3):563-75, x. PubMed ID: 10853142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical assessment of outcome of prostate cancer (TCP, NTCP).
    Perez CA; Michalski J; Mansur D
    Rays; 2005; 30(2):109-20. PubMed ID: 16294903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCP and NTCP in preclinical and clinical research in Europe.
    Baumann M; Petersen C; Krause M
    Rays; 2005; 30(2):121-6. PubMed ID: 16294904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CalcNTCP: a simple tool for computation of normal tissue complication probability (NTCP) associated with cancer radiotherapy.
    Khan HA
    Int J Radiat Biol; 2007 Oct; 83(10):717-20. PubMed ID: 17729166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of traditional and simultaneous IMRT boost technique basing on therapeutic gain calculation.
    Slosarek K; Zajusz A; Szlag M
    Med Dosim; 2008; 33(4):299-302. PubMed ID: 18973858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of dose and volume on radiation-induced mucositis.
    Mantini G; Manfrida S; Cellini F; Giammarino D; Petrone A; Vitucci P; Cellini N
    Rays; 2005; 30(2):137-44. PubMed ID: 16294906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy.
    Hey J; Setz J; Gerlach R; Vordermark D; Gernhardt CR; Kuhnt T
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1475-80. PubMed ID: 19515505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
    Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
    Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning.
    Cella L; Ciscognetti N; Martin G; Liuzzi R; Punzo G; Solla R; Farella A; Salvatore M; Pacelli R
    Med Dosim; 2009; 34(1):75-81. PubMed ID: 19181259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of spatial dose gradients and probability density function to evaluate the effect of internal organ motion for prostate IMRT treatment planning.
    Jiang R; Barnett RB; Chow JC; Chen JZ
    Phys Med Biol; 2007 Mar; 52(5):1469-84. PubMed ID: 17301465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future issues in highly conformal radiotherapy for head and neck cancer.
    Feng M; Eisbruch A
    J Clin Oncol; 2007 Mar; 25(8):1009-13. PubMed ID: 17350951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple method to calculate the influence of dose inhomogeneity and fractionation in normal tissue complication probability evaluation.
    Begnozzi L; Gentile FP; Di Nallo AM; Chiatti L; Zicari C; Consorti R; Benassi M
    Strahlenther Onkol; 1994 Oct; 170(10):590-4. PubMed ID: 7974170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiobiological predictors of tumor and acute normal tissue response in radiotherapy for head and neck cancers.
    Maciejewski B; Skladowski K; Zajusz A
    Neoplasma; 1991; 38(5):513-22. PubMed ID: 1956467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of visual acuity in carbon ion radiotherapy: analysis of dose-volume histograms and prognostic factors.
    Hasegawa A; Mizoe JE; Mizota A; Tsujii H
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):396-401. PubMed ID: 16182466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult.
    Ho KF; Fowler JF; Sykes AJ; Yap BK; Lee LW; Slevin NJ
    Acta Oncol; 2009; 48(3):431-9. PubMed ID: 18781445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose painting: art or science?
    Tanderup K; Olsen DR; Grau C
    Radiother Oncol; 2006 Jun; 79(3):245-8. PubMed ID: 16725221
    [No Abstract]   [Full Text] [Related]  

  • 20. [Constraints to organs at risk for treatment of head and neck cancers by intensity modulated radiation therapy].
    Maingon P; Mammar V; Peignaux K; Truc G; Barillot I
    Cancer Radiother; 2004 Aug; 8(4):234-47. PubMed ID: 15450517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.